These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19781306)

  • 21. [Drug-eluting stents in multivessel coronary artery disease: Was one of the important fortresses of surgery conquered?].
    Okmen AS; Okmen E
    Anadolu Kardiyol Derg; 2009 Aug; 9(4):325-30. PubMed ID: 19666436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effective and efficient strategies for coronary revascularization in the drug-eluting stent era.
    Lepor NE; Madyoon H; Kereiakes D
    Rev Cardiovasc Med; 2002; 3 Suppl 5():S38-50. PubMed ID: 12478234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Avoiding restenosis: is there a role for glucocorticoids in the drug-eluting stent era?
    Jimenez-Valero S; Moreno R; Sanchez-Recalde A; Galeote G; Calvo L; Viana A; Lopez de Sá E; López-Sendón J
    Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):137-46. PubMed ID: 19124417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of patients with in-stent restenosis.
    Alfonso F; Pérez-Vizcayno MJ; Cruz A; García J; Jimenez-Quevedo P; Escaned J; Hernandez R
    EuroIntervention; 2009 May; 5 Suppl D():D70-8. PubMed ID: 19736076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interfacial biology of in-stent restenosis.
    Santin M; Colombo P; Bruschi G
    Expert Rev Med Devices; 2005 Jul; 2(4):429-43. PubMed ID: 16293082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular brachytherapy and the strontium90 vascular brachytherapy system.
    Reisman M; Gray WA
    J Invasive Cardiol; 2003 Sep; 15(9):520-2; quiz 523. PubMed ID: 12947213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical trials of intracoronary gamma radiation therapy for in-stent restenosis.
    Cha DH; Ajani AE; Cheneau E; Waksman R
    J Invasive Cardiol; 2002 Jul; 14(7):432-7. PubMed ID: 12082202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Progress on reasech of drug-coated stent].
    Zhang L; Liu J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Feb; 24(1):235-9. PubMed ID: 17333930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-eluting stents: a pharmacoclinical perspective.
    Thomas MK; Gupta YK
    Natl Med J India; 2006; 19(4):195-9. PubMed ID: 17100106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
    Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
    Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coronary restenotic reduction of drug-eluting stenting may be due to its anti-inflammatory effects.
    Li JJ; Li J; Nan JL; Li Z; Zhen X; Mu CW; Dai J; Zhang CY
    Med Hypotheses; 2007; 69(5):1004-9. PubMed ID: 17499449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restenosis in percutaneous coronary intervention--is drug-eluting stent the answer?
    Lim VY; Lim YL
    Singapore Med J; 2003 Sep; 44(9):482-7. PubMed ID: 14740779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-eluting stents: a reappraisal.
    Garg S; Serruys PW
    Heart; 2010 Apr; 96(7):489-93. PubMed ID: 20350985
    [No Abstract]   [Full Text] [Related]  

  • 35. Vascular brachytherapy for patients with drug-eluting stent restenosis.
    Bonello L; Kaneshige K; De Labriolle A; Roy P; Lemesle G; Torguson R; Satler LF; Pichard AD; Lindsay J; Waksman R
    J Interv Cardiol; 2008 Dec; 21(6):528-34. PubMed ID: 18973502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-eluting stent: the emerging technique for the prevention of restenosis.
    Sheiban I; Carrieri L; Catuzzo B; Destefanis P; Oliaro E; Moretti C; Trevi GP
    Minerva Cardioangiol; 2002 Oct; 50(5):443-53. PubMed ID: 12384626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammatory response, drug-eluting stent and restenosis.
    Li JJ
    Chin Med J (Engl); 2008 Mar; 121(6):566-72. PubMed ID: 18364149
    [No Abstract]   [Full Text] [Related]  

  • 38. [Late stent thrombosis thirteen months after drug-eluting stent implantation].
    Sacha J; Wester A; Pluta W
    Kardiol Pol; 2008 Jan; 66(1):78-80; discussion 84-5. PubMed ID: 18266191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mounting evidence for safety and improved outcomes of drug-eluting stenting: but is it the stent?
    King SB; Hannan EL
    Circulation; 2008 Oct; 118(18):1783-4. PubMed ID: 18852362
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical presentation of patients with in-stent restenosis in the drug-eluting stent era.
    Lee MS; Pessegueiro A; Zimmer R; Jurewitz D; Tobis J
    J Invasive Cardiol; 2008 Aug; 20(8):401-3. PubMed ID: 18688064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.